- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Lenalidomide (Revlimid®)
Total 14716 results
-
CelgeneRecruitingLymphoma, Mantle-CellSpain, Italy, Germany, Austria, France, Greece, Netherlands
-
Institut de Cancérologie de la LoireCelgene CorporationCompletedLeukemia, Lymphoid | Precursor B-Cell Lymphoblastic Leukemia-LymphomaFrance
-
CelgeneTerminatedT-cell Non-Hodgkin's LymphomaFrance, United States, Australia, Belgium
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Celgene CorporationCompletedProstate CancerUnited States
-
Jun ZhangBaylor College of Medicine; Celgene CorporationTerminatedCarcinoma, Non-Small-Cell LungUnited States
-
Beth Israel Deaconess Medical CenterTerminated
-
National Cancer Institute (NCI)Completed
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Celgene CorporationTerminatedMyelodysplastic Syndrome | MDS | Low to Intermediate-1 MDS | Non-deletion 5qUnited States
-
Washington University School of MedicineCompletedMyelodysplastic SyndromesUnited States
-
CelgeneTerminatedNon-Hodgkin's Lymphoma | Mantle Cell LymphomaUnited States, Spain, United Kingdom, Germany, France, Czechia, Israel, Italy, Poland, Portugal, Puerto Rico, Russian Federation
-
Duke UniversityCelgene CorporationCompletedMyelodysplastic SyndromesUnited States
-
James RubensteinIncyte CorporationRecruitingPrimary Central Nervous System Lymphoma | CNS Lymphoma | Secondary Central Nervous System LymphomaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
Kenneth AinCelgene CorporationCompletedThyroid NeoplasmsUnited States
-
CelgeneCompleted
-
M.D. Anderson Cancer CenterCelgeneCompletedLeukemia | Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | CLLUnited States
-
Washington University School of MedicineCompletedLeukemia, Myeloid, AcuteUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationCompletedMyelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
CelgeneCompletedB-cell Chronic Lymphocytic LeukemiaUnited States, Spain, United Kingdom, Canada, Belgium, Czechia, Hungary, Italy, Poland, Israel, Germany, Ireland, France, New Zealand, Denmark, Australia, Netherlands, Romania, Russian Federation, Sweden, Austria, South Africa, Colo... and more
-
The Lymphoma Academic Research OrganisationCompletedLymphoma | Diffuse Large B-cell LymphomaBelgium, Switzerland, France, Australia, Spain, Israel, Austria, Portugal, Poland
-
Peter MacCallum Cancer Centre, AustraliaCompletedHodgkin Lymphoma | Lymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, PeripheralAustralia
-
University of ChicagoJanssen Scientific Affairs, LLC; AmgenRecruitingMultiple Myeloma | MyelomaUnited States
-
Hackensack Meridian HealthCelgene CorporationCompletedDiffuse Large B Cell LymphomaUnited States
-
CelgeneCompletedMyelodysplastic SyndromeSpain, United Kingdom, Denmark, Germany, France, Greece, Italy, Sweden, Belgium, United States, Luxembourg, Norway
-
M.D. Anderson Cancer CenterCompleted
-
Jason Robert GotlibCelgene CorporationTerminatedLeukemia | Anemia | Myelodysplastic Syndromes (MDS) | Acute Myeloid Leukemia (AML)United States
-
The Christie NHS Foundation TrustCelgene Corporation; Leukemia Research FundTerminatedChronic Lymphocytic LeukaemiaUnited Kingdom
-
Icahn School of Medicine at Mount SinaiCelgeneTerminatedUrinary Bladder NeoplasmsUnited States
-
Duke UniversityCelgeneTerminatedFollicular Lymphoma | Marginal Zone LymphomaUnited States
-
Yale UniversityPeter MacCallum Cancer Centre, AustraliaTerminatedMultiple Myeloma | Hodgkin's Lymphoma | Mature T-cell LymphomaUnited States
-
Scripps HealthBristol-Myers Squibb; Celgene CorporationWithdrawnLeukemia | Chronic Lymphocytic Leukemia
-
UMC UtrechtCelgene CorporationCompletedMultiple MyelomaNetherlands
-
University of California, DavisCelgeneCompletedAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Kaposi Sarcoma | AIDS-Related Kaposi SarcomaUnited States
-
Gesellschaft fur Medizinische Innovation - Hamatologie...CompletedComparison of 25mg Versus 5 mg Lenalidomide as Maintenance Therapy in Patients With Multiple MyelomaMultiple MyelomaGermany
-
OncoPep, Inc.CompletedSmoldering Multiple MyelomaUnited States
-
Arbeitsgemeinschaft medikamentoese TumortherapieCelgeneCompletedChronic Lymphocytic Leukemia | CLLAustria
-
M.D. Anderson Cancer CenterCelgene CorporationTerminatedPain | Advanced CancerUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationCompletedLeukemia | Chronic Lymphocytic LeukemiaUnited States
-
Gesellschaft fur Medizinische Innovation - Hamatologie...ClinAssess GmbHCompleted
-
University Health Network, TorontoCompletedMultiple Myeloma | AmyloidosisCanada
-
H. Lee Moffitt Cancer Center and Research InstituteCelgene CorporationCompletedMyelodysplastic Syndrome | MDSUnited States
-
Hospital Universitario GetafeUnknown
-
Massachusetts General HospitalMillennium Pharmaceuticals, Inc.; Celgene CorporationActive, not recruitingAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
Dr. med. Lars-Olof MueggeTerminatedMultiple MyelomaGermany
-
AmgenCompletedRelapsed Multiple MyelomaUnited States, Canada
-
Bristol-Myers SquibbCompletedMultiple MyelomaUnited States, France, Australia
-
Fundación General de la Universidad de SalamancaCelgene CorporationCompletedMyelodysplastic SyndromeGermany, Spain, France
-
TG Therapeutics, Inc.TerminatedMantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Waldenstrom's Macroglobulinemia | Non-Hodgkins Lymphoma | Small Lymphocytic Lymphoma | B-cell LymphomasUnited States
-
CelgeneWithdrawnNeoplasms | Hematologic Diseases | Multiple Myeloma | Paraproteinemias | Blood Protein Disorders | Therapeutic Uses | Plasma Cells